| 发明名称 |
SUSTAINED RELEASE DOSAGE FORMS OF ZIPRASIDONE |
| 摘要 |
A sustained release solid oral dosage form for treatment of a psychotic disorder, for example schizophrenia, in a mammal is provided, which oral dosage form comprises ziprasidone in an amount effective in treating said psychotic disorder and a pharmaceutically acceptable carrier.
|
| 申请公布号 |
US2010003331(A1) |
申请公布日期 |
2010.01.07 |
| 申请号 |
US20090261678 |
申请日期 |
2009.09.03 |
| 申请人 |
PFIZER INC. |
发明人 |
AHMED IMRAN;APPEL LEAH ELIZABETH;BABCOCK WALTER CHRISTIAN;FRIESEN DWAYNE THOMAS;HERBIG SCOTT;LYON DAVID KEITH;SHAMBLIN SHERI L.;SHANKER RAVI MYSORE;SMITHEY DANIEL TOD;SUTTON STEVEN C.;THOMBRE AVINASH GOVIND;WATERMAN KENNETH C.;SHAH JAYMIN C.;SHAH PARAG SURESH;WISNIECKI PETER;WAGNER DAWN RENEE |
| 分类号 |
A61K9/14;A61K9/00;A61K9/16;A61K9/20;A61K9/52;A61K31/496;A61K31/501 |
主分类号 |
A61K9/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
